Feuille James sold $14.7M of CHYM (indirect holdings)

Feuille James sold 447,637 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $32.89 ($31.46–$34.41, $14.72M total) across 7 trades over 2026-09-14 to 2026-09-16.

Original reporting
SEC EDGAR · Feuille James
Published Sep 16, 2026, 10:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Bearish
medium confidence
Mentioned
$CHYM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMBearishLow
01

Why it matters

The complete divestiture by a director may be interpreted as a negative signal, but the market may already price in typical insider sales.

02

Market read

Primary disclosure of a sizable insider sell; modest trading relevance for short-term traders.

03

What to watch

Potential tax planning or liquidity needs for the director; no disclosed performance concerns.

Relevance 7/10Novelty 7/10Timing: Filed today (Sept 16, 2026)

Background

SEC Form 4 filing discloses insider transactions; required to be made public promptly.

Company-level read

Ticker impact

$CHYMBearishMedium confidence
Context

Director James Feuille sold all 447,637 shares for $14.7M, reducing his stake to zero.

Expected impact

Potential short-term downward pressure on CHYM stock.

Evidence & confidence

A $14.7M sale by a director is material and suggests possible negative sentiment, but no immediate catalyst beyond the filing.

Market effects

May weigh on fintech/online banking sector sentiment as insider sell signals risk.

Limited to U.S. markets where CHYM trades.

Low; impact confined to CHYM and its niche sector.

Counterpoint

The sale could be unrelated to company fundamentals; could present a buying opportunity if price overreacts.

Key entities

  • Chime Financial, Inc.

    U.S.-listed fintech firm (ticker CHYM).

  • James Feuille

    Director of Chime Financial who sold his entire stake.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.